• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Clarivate Unveils Citation Laureates 2025 - Highlighting Nobel-Class Research with Global Impact

    9/25/25 3:00:00 AM ET
    $CLVT
    EDP Services
    Technology
    Get the next $CLVT alert in real time by email

    22 Researchers Recognized, Including First Citation Laureate Based in Mainland China

    LONDON, Sept. 25, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the Citation Laureates 2025 – a distinguished group of 22 researchers whose work is of Nobel class. Selected by experts at the Institute for Scientific Information (ISI) at Clarivate, these individuals have made pioneering contributions that are shaping the future of science and society.

    Clarivate logo (PRNewsfoto/Clarivate Analytics)

    Since the program's inception, 83 Citation Laureates have gone on to receive Nobel Prizes, often years after their initial recognition by Clarivate.

    Citation Laureates' foundational research papers rank among the most highly cited in their fields, reflecting exceptional influence across disciplines and borders. This year's Laureates have advanced knowledge in fields of urgent global relevance, including:

    • Physiology or Medicine: Leukemia, appetite regulation, and immune system research
    • Physics: Signal processing, quantum computing, interstellar chemistry, and image compression
    • Chemistry: Energy storage, green chemistry, sustainable energy, and cell engineering
    • Economics: Remote work, automation, inequality, poverty, and the economic impact of culture and discrimination

    The 2025 Laureates are affiliated with leading academic institutions in eight countries/regions. Ten are based in the United States, three in France, two each in Germany, Japan, and Switzerland, and one each in Canada, the Netherlands, and – for the first time – Mainland China.

    Tao Zhang, Academician of the Chinese Academy of Sciences and Professor at the Dalian Institute of Chemical Physics, is recognized for pioneering work in single-atom catalysis, a breakthrough that enables more efficient and sustainable chemical reactions. His selection as the first Citation Laureate based in Mainland China reflects the country's growing influence in global science. According to the latest G20 research and innovation scorecard from ISI, Mainland China led the G20 in research output in 2024 with nearly 900,000 papers — triple its 2015 volume.

    Tao Zhang, Academician of the Chinese Academy of Sciences and Professor at the Dalian Institute of Chemical Physics, said: "It is my great honor to receive the Citation Laureates 2025 award, which is a full recognition of the originality and international impact of our work. In the past, my collaborators and I created the concept of Single-Atom Catalysis by standing on the shoulders of others. Looking ahead, I hope that more young scientists will stand on our shoulders to drive catalysis and chemistry to a higher level. I believe that the integration of Single-Atom Catalysis with artificial intelligence will shape a new paradigm of atomically precise catalysis, making catalyst rational design possible and accelerating the advancement of global new energy and green chemical industries."

    Emmanuel Thiveaud, Senior Vice President for Research & Analytics, Academia & Government at Clarivate, said: "Each year, the Citation Laureates program highlights researchers whose work has transformed their disciplines and delivered profound societal impact. Their research is not only highly cited but deeply influential. At Clarivate, we are proud to honor these pioneers whose contributions often foreshadow Nobel recognition and help shape a better future."

    Since 2002, ISI analysts have used publication and citation data from the Web of Science Core Collection to identify potential Nobel Prize recipients. Out of 64 million articles and proceedings indexed since 1970, less than 0.02% have been cited more than 2,000 times. Citation Laureates are selected from this elite group through rigorous citation analysis and expert insight.

    The Citation Laureates 2025 are:

    Physiology or Medicine

    Andrea Ablasser, Professor, Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland

    Glen N. Barber, Professor, Department of Surgery/Div Surg Oncology, Klotz Chair in Cancer Research, and Director of the Center for Innate Immunity and Inflammation, Pelotonia Institute for Immuno-Oncology, The James Cancer Center, Ohio State University, Columbus, Ohio, United States

    Zhijian 'James' Chen, George L. MacGregor Distinguished Chair in Biomedical Science, Director of the Inflammation Research Center, and Professor of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, United States; Howard Hughes Medical Institute Investigator

    "for elucidating the cGAS-STING pathway, a fundamental mechanism of innate immunity"

    John E. Dick, Senior Scientist, Princess Margaret Cancer Centre, and Helga and Antonio De Gasperis Chair in Blood Cancer Stem Cell Research, University Health Network; Professor, Department of Molecular Genetics, and University Professor, University of Toronto, Toronto, Canada

    "for identifying leukemia stem cells and establishing their relevance in therapy failure and disease recurrence, thereby shifting the focus for many types of cancer and their treatments"

    Kenji Kangawa, Former Director General of the Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan

    Masayasu Kojima, Professor Emeritus, Institute for Molecular Biosciences, Institute of Life Science, Kurume University, Kurume, Fukuoka, Japan

    "for discovery of ghrelin, a hormone regulating appetite, energy, and metabolism"

    Physics

    Ingrid Daubechies, James B. Duke Distinguished Professor Emerita of Mathematics, Duke University, Durham, North Carolina, United States

    Stéphane Mallat, Professor, Chair of Data Sciences, Collège de France, Paris, France

    Yves Meyer, Professor Emeritus of Mathematics, École Normale Supérieure Paris-Saclay, Paris, France

    "for advancing wavelet theory, a revolution in mathematics and physics with practical applications including image processing"

    David P. DiVincenzo, Director, Institute of Theoretical Nanoelectronics, Peter Grünberg Institute, Forschungszentrum Jülich, Jülich, Germany; Professor, Institute for Quantum Information, RWTH Aachen University, Aachen, Germany

    Daniel Loss, Professor, Theoretical Physics, Director of the Center for Quantum Computing and Quantum Coherence (QC2), and Co-Director of National Center on Spin Qubits (NCCR SPIN), University of Basel, Basel, Switzerland

    "for proposing the Loss-DiVincenzo model for quantum computing, using electron spins in quantum dots as qubits"

    Ewine F. van Dishoeck, Professor of Molecular Astrophysics, Leiden University, Leiden, The Netherlands; External Scientific Member, Max Planck Institute for Extraterrestrial Physics, Garching, Germany

    "for pioneering contributions to astrochemistry revealing interstellar molecular clouds and their role in star and planet formation"

    Chemistry

    Clifford P. Brangwynne, Director, Omenn-Darling Bioengineering Institute, June K. Wu '92 Professor in Engineering, and Professor of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey, United States; Howard Hughes Medical Institute Investigator

    Anthony A. Hyman, Director and Research Group Leader, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany

    Michael K. Rosen, Mar Nell and F. Andrew Bell Distinguished Chair of the Biophysics Department, Investigator of the Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, United States

    "for discoveries on the role of phase-separated biomolecular condensates in biochemical organization of the cell"

    Jean-Marie Tarascon, Professor of Chemistry, Collège de France, Paris, France

    "for fundamental advances and novel applications in energy storage and conversion technology"

    Tao Zhang, Academician of Chinese Academy of Sciences, and Professor, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Mainland China

    "for seminal contributions to the development of Single-Atom Catalysis and applications"

    Economics

    David Autor, Daniel (1972) and Gail Rubinfeld Professor, Department of Economics, MIT, Cambridge, Massachusetts, United States

    Lawrence F. Katz, Elisabeth Allison Professor of Economics, Department of Economics, Harvard University, Cambridge, Massachusetts, United States

    "for seminal analysis of wage structure, earnings inequality, educational advance, and technological change"

    Marianne Bertrand, Chris P. Dialynas Distinguished Service Professor of Economics, University of Chicago Booth School of Business, Chicago, Illinois, United States

    Sendhil Mullainathan, Peter de Florez Professor, Electrical Engineering and Computer Science and Economics (Dual Appointment), MIT, Cambridge, Massachusetts, United States

    "for joint research on racial discrimination, corporate governance, and other aspects of labor economics determined by psychology and culture"

    Nicholas Bloom, William Eberle Professor of Economics, Department of Economics, Stanford University, Stanford, California, United States

    "for analyzing the impact of economic and political uncertainty on investment, employment and growth"

     

    While the Citation Laureates program does not aim to predict Nobel Prize recipients in a specific year, it highlights researchers whose work is of Nobel class and deserving of global recognition.

    Notes to editors:

    • Learn more about the Citation Laureates selection methodology and explore the research contributions of this year's Laureates on the Clarivate blog.
    • View the full list of Citation Laureates named since 2002 in the Hall of Citation Laureates.
    • David Pendlebury, Head of Research Analysis at the Institute for Scientific Information at Clarivate, is available for interview.
    • The 2025 Nobel Prize announcements will take place from 6–13 October and will be streamed live at www.nobelprize.org.

    About Clarivate

    Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

    Media contact:

    Rebecca Krahenbuhl, Senior Manager, External Communications, Academia & Government

    [email protected] 

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-unveils-citation-laureates-2025--highlighting-nobel-class-research-with-global-impact-302566388.html

    SOURCE Clarivate Plc

    Get the next $CLVT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLVT

    DatePrice TargetRatingAnalyst
    1/8/2026$3.60Buy → Neutral
    Goldman
    12/17/2025$3.00Equal-Weight → Underweight
    Morgan Stanley
    9/3/2025Peer Perform
    Wolfe Research
    7/18/2025$4.50Buy → Hold
    Jefferies
    11/6/2024Outperform → Mkt Perform
    William Blair
    12/15/2023$8.00Equal Weight → Underweight
    Wells Fargo
    10/16/2023$10.00 → $8.50Hold → Buy
    Jefferies
    9/8/2023$8.00 → $7.00Equal Weight → Underweight
    Barclays
    More analyst ratings

    $CLVT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cornick Kenneth L. bought $345,000 worth of Ordinary Shares (100,000 units at $3.45) (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    11/13/25 8:51:35 AM ET
    $CLVT
    EDP Services
    Technology

    Director Cornick Kenneth L. bought $2,482,000 worth of Ordinary Shares (725,000 units at $3.42) (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    11/3/25 7:20:21 PM ET
    $CLVT
    EDP Services
    Technology

    Director Snyder Andrew Miles bought $4,861,800 worth of Ordinary Shares (1,460,000 units at $3.33) (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    11/3/25 5:16:01 PM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Vice President/CFO Collins Jonathan Mark was granted 35,573 units of Ordinary Shares and covered exercise/tax liability with 17,396 units of Ordinary Shares, increasing direct ownership by 2% to 795,224 units (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    2/20/26 4:57:18 PM ET
    $CLVT
    EDP Services
    Technology

    President, LS&H Levy Henry was granted 36,847 units of Ordinary Shares and covered exercise/tax liability with 18,115 units of Ordinary Shares, increasing direct ownership by 3% to 698,652 units (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    2/20/26 4:57:13 PM ET
    $CLVT
    EDP Services
    Technology

    Senior VP, Finance/CAO Easton Michael M was granted 7,114 units of Ordinary Shares and covered exercise/tax liability with 3,521 units of Ordinary Shares, increasing direct ownership by 0.73% to 497,764 units (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    2/20/26 4:57:08 PM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $CLVT
    SEC Filings

    View All

    $CLVT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Clarivate downgraded by Goldman with a new price target

    Goldman downgraded Clarivate from Buy to Neutral and set a new price target of $3.60

    1/8/26 8:37:08 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Clarivate from Equal-Weight to Underweight and set a new price target of $3.00

    12/17/25 8:52:26 AM ET
    $CLVT
    EDP Services
    Technology

    Wolfe Research initiated coverage on Clarivate

    Wolfe Research initiated coverage of Clarivate with a rating of Peer Perform

    9/3/25 8:37:02 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Plc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CLARIVATE PLC (0001764046) (Filer)

    2/3/26 8:24:37 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Plc filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - CLARIVATE PLC (0001764046) (Filer)

    2/2/26 7:42:36 AM ET
    $CLVT
    EDP Services
    Technology

    SEC Form S-3ASR filed by Clarivate Plc

    S-3ASR - CLARIVATE PLC (0001764046) (Filer)

    11/4/25 7:53:21 AM ET
    $CLVT
    EDP Services
    Technology

    Impactive Capital Nominates Four Candidates to WEX Board

    Contends Board Level Change is Required to Address Alarming Share Price Underperformance, Culture of Entrenchment and Widening Valuation Gap Versus Its Closest Peer Nominees Kurt Adams, Ellen Alemany, Ken Cornick and Lauren Taylor Wolfe Each Bring an Owner's Perspective and the Relevant Industry Experience to Strengthen Strategic Oversight, Enhance Capital Allocation and Improve Operational Performance Nominees Have Demonstrated Conviction in WEX's Value Potential and Personally Purchased More Shares Than the Entire Incumbent Board Over the Past Nine Years Impactive Capital, LP, ("Impactive" or "we") together with its affiliates, one of the largest shareholders of WEX Inc. (NYSE:WEX)

    2/9/26 8:00:00 AM ET
    $ADP
    $CLVT
    $CPAY
    Diversified Commercial Services
    Industrials
    EDP Services
    Technology

    Clarivate Webinar "Intelligence Amplified in the Age of AI" Highlights How Trusted, Proprietary Data Powers Next‑Generation Innovation

    LONDON, Feb. 3, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of a video webinar, Intelligence Amplified in the Age of AI, an in‑depth session exploring how Clarivate is leveraging artificial intelligence to  reshape research, innovation, and decision‑making across the scientific, academic, intellectual property, and life sciences ecosystems. Hosted by Matti Shem Tov, Chief Executive Officer of Clarivate, the webinar unveils how Clarivate is applying cutting-edge AI technology to amplify the

    2/3/26 8:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Announces Full Redemption of Remaining $100 Million Senior Secured Notes Due 2026 and Provides Update on Capital Allocation Activities

    LONDON, Feb. 2, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced that its subsidiary, Camelot Finance S.A., has redeemed the remaining $100 million aggregate principal amount of its 4.50% senior secured notes due 2026, originally issued on October 31, 2019 (the "2026 Notes"). The 2026 Notes were redeemed on January 30, 2026 (the "Redemption Date") at a cash redemption price equal to 100% of the remaining principal amount, or $100 million, plus accrued and unpaid interest through the Redemption Date. With

    2/2/26 7:30:00 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Financials

    Live finance-specific insights

    View All

    Impactive Capital Nominates Four Candidates to WEX Board

    Contends Board Level Change is Required to Address Alarming Share Price Underperformance, Culture of Entrenchment and Widening Valuation Gap Versus Its Closest Peer Nominees Kurt Adams, Ellen Alemany, Ken Cornick and Lauren Taylor Wolfe Each Bring an Owner's Perspective and the Relevant Industry Experience to Strengthen Strategic Oversight, Enhance Capital Allocation and Improve Operational Performance Nominees Have Demonstrated Conviction in WEX's Value Potential and Personally Purchased More Shares Than the Entire Incumbent Board Over the Past Nine Years Impactive Capital, LP, ("Impactive" or "we") together with its affiliates, one of the largest shareholders of WEX Inc. (NYSE:WEX)

    2/9/26 8:00:00 AM ET
    $ADP
    $CLVT
    $CPAY
    Diversified Commercial Services
    Industrials
    EDP Services
    Technology

    Clarivate to Report Fourth Quarter and Full Year 2025 Results on February 24, 2026

    LONDON, Jan. 28, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the fourth quarter and full year 2025 before the market opens on Tuesday, February 24, 2026. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Tuesday, February 24, 2026 to review the results. The webcast is o

    1/28/26 8:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Reports Third Quarter 2025 Results

    — Continued acceleration of organic ACV — — Raises 2025 Revenues Outlook — — Repurchased 11.7 million ordinary shares and repaid $100 million of debt in the third quarter — LONDON, Oct. 29, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the third quarter ended September 30, 2025. "The third quarter demonstrated continued improved financial and operational performance, underscoring the effectiveness of our Value Creation Plan and the increased focus, growth and i

    10/29/25 6:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Leadership Updates

    Live Leadership Updates

    View All

    VideoAmp Expands Board with Former Tech and Data Industry Leaders Jonathan Gear and Sari Granat

    Seasoned executives from Clarivate, IHS Markit and Chainalysis join to guide next-phase innovation and scaling at VideoAmp VideoAmp, a leading advertising technology company, today announced the appointment of Jonathan Gear and Sari Granat to its Board of Directors. Gear and Granat bring extensive leadership experience across information services, SaaS, analytics, and global technology, strengthening VideoAmp's mission to modernize measurement and deliver higher fidelity, outcome-based currency for the industry. Jonathan Gear most recently served as Chief Executive Officer of Clarivate (NYSE:CLVT), a global information and analytics company, where he led a strategic repositioning to drive

    12/2/25 9:00:00 AM ET
    $AIZ
    $CLVT
    $INFO
    Property-Casualty Insurers
    Finance
    EDP Services
    Technology

    Clarivate Announces Maroun S. Mourad as President, Intellectual Property

    LONDON, July 30, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced that Maroun S. Mourad will join the Company as President of the Intellectual Property (IP) segment, effective September 8, 2025. Maroun most recently served as President of the Claims Solutions division of Verisk Analytics Inc. He succeeds Gordon Samson, who will retire at the end of 2025 after a high-impact career in the IP industry, spending five years as the Chief Operating Officer at CPA Global, before joining the Clarivate executive team, most recently as the President of the IP segment.

    7/30/25 6:01:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Appoints Henry Levy as President, Life Sciences & Healthcare

    Concludes the appointments for business leaders of its three market segments LONDON, April 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that it has appointed Henry Levy as President, Life Sciences & Healthcare, effective May 1, 2023. Henry joins from Veeva Systems, a global leader in cloud software for the life sciences industry, where he most recently served as President, Global R&D and Quality, with responsibility for driving sales across the segment. Jonathan Gear,

    4/26/23 7:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Clarivate Plc

    SC 13G/A - CLARIVATE PLC (0001764046) (Subject)

    12/5/24 10:02:09 AM ET
    $CLVT
    EDP Services
    Technology

    SEC Form SC 13G filed by Clarivate Plc

    SC 13G - CLARIVATE PLC (0001764046) (Subject)

    11/13/24 4:18:30 PM ET
    $CLVT
    EDP Services
    Technology

    SEC Form SC 13D/A filed by Clarivate Plc (Amendment)

    SC 13D/A - CLARIVATE PLC (0001764046) (Subject)

    3/4/24 9:01:44 AM ET
    $CLVT
    EDP Services
    Technology